Healthcare / BiotechnologyUpdated 2026-05-10 22:07 UTC

TSX/HBP stock hub

TSX/HBP has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

TSX/HBPis not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

125.3M

Toronto Stock Exchange

Market data

Live price

Current market quote for this ticker.

Current price

TSX/HBP

In the news

Latest news · TSX/HBP

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/En/a

P25 11P50 15.6P75 25.4

Trailing P/En/a

P25 7.4P50 15.6P75 34.3

ROE-54.7

P25 -121.5P50 -40.9P75 0.5

ROIC-32.8

P25 -72.5P50 -16P75 1.4

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All TSX/HBP market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

153

Groups with data

Currency

CAD

Showing 153 of 153 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Country	Canada
Country code	CA
Employees	7
Employees Change	-2%
Employees Change Percent	-22.22
Enterprise value	CAD 125.6M
Exchange	Toronto Stock Exchange
Financial currency	CAD
First seen	2026-05-10
Industry	Biotechnology
Isin	CA4229101098
Last refreshed	2026-05-10
Market cap	CAD 125.3M
Price	CAD 1.64
Price currency	CAD
Sector	Healthcare
Sic	2834
Symbol	tsx/HBP
Website	https://www.helixbiopharma.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	-3.35%
EV Earnings	-29.93x
P/B ratio	8.15x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
Net Income	CAD -4.2M
Net Income Growth Quarters	4%
Net Income Growth Years	1%
Profit Per Employee	CAD -599,429
ROA	-24.8
Roa5y	-176.4
ROCE	-26.83
ROE	-54.7
ROIC	-32.81

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr10y	-16.16%
Cagr15y	-13.68%
Cagr1y	70.9%
Cagr20y	-10.76%
Cagr3y	17.92%
Cagr5y	-19.16%
EPS Growth Quarters	3
EPS Growth Years	1
Revenue Growth Years	0x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Assets	CAD 18.5M
Cash	CAD 31,000
Current Assets	CAD 135,000
Current Liabilities	CAD 3.2M
Debt	CAD 360,000
Debt Equity	CAD 0.02
Equity	CAD 15.4M
Interest Coverage	-164.8
Liabilities	CAD 3.2M
Long Term Assets	CAD 18.4M
Long Term Liabilities	CAD 0
Net Cash	CAD -329,000
Net Cash By Market Cap	CAD -0.26
Net Debt Equity	CAD 0.02
Tangible Book Value	CAD -3M
Tangible Book Value Per Share	CAD -0.04
WACC	2.54

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	0.04
Net Working Capital	CAD -2.7M
Quick ratio	0.02
Working Capital	CAD -3M

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-42.44%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
10Y total return	-82.83%
1Y total return	70.83%
200-day SMA	1.87
3Y total return	64%
50-day SMA	1.89
50-day SMA vs 200-day SMA	50over200
5Y total return	-65.47%
All Time High	40.25
All Time High Change	-95.93%
All Time High Date	2000-10-10
All Time Low	0.3
All Time Low Change	446.67%
All Time Low Date	1998-08-17
ATR	0.15
Beta	-0.31
Beta1y	3.22
Beta2y	1.73
Ch YTD	-30.8
High	1.64
High52	5.4
High52 Date	2025-10-06
High52ch	-69.63%
Low	1.6
Low52	0.84
Low52 Date	2025-06-30
Low52ch	95.24%
Ma50ch	-13.41%
Price vs 200-day SMA	-12.16%
RSI	38.27
RSI Monthly	52.33
RSI Weekly	44.18
Sharpe ratio	1x
Sortino ratio	1.75
Total Return	-42.44%
Tr YTD	-30.8
Tr15y	-88.99%
Tr1m	0.61%
Tr1w	-22.27%
Tr3m	-10.38%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Operating Income	CAD -4.1M

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	54,266,880%
Shares Insiders	1.44%
Shares Out	76,378,098
Shares Qo Q	0.67%
Shares Yo Y	42.44%

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Average Volume	4,422.1x
Bv Per Share	0.2
Ch10y	-82.83
Ch15y	-88.99
Ch1m	0.61
Ch1w	-22.27
Ch1y	70.83
Ch20y	-89.75
Ch3m	-10.38
Ch3y	64
Ch5y	-65.47
Ch6m	-21.9
Change	0%
Change From Open	2.5
Close	1.64
Days Gap	-2.44
Depreciation Amortization	7,000
Dollar Volume	2,437
Earnings Date	2026-06-12
EBIT	CAD -4.1M
EBITDA	CAD -4.1M
EPS	CAD -0.06
F Score	1
Financing CF	1,743,000
Fiscal Year End	July
Founded	2,008
Is Primary Listing	1
Last Earnings Date	2025-12-12
Last Report Date	2026-01-31
Last Split Date	2024-08-16
Last Split Type	Reverse
Ma150	2.11
Ma150ch	-22.35%
Ma20	1.92
Ma20ch	-14.41%
Net CF	-1,965,000
Next Earnings Date	2026-06-12
Open	1.6
Position In Range	100
Ppne	1,000
Price Date	2026-05-08
Relative Volume	0.34x
Share Based Comp	82,000
Tr20y	-89.75%
Tr6m	-21.9%
Volume	1,486

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

Does TSX/HBP pay a dividend?

Capital-return profile for this ticker.

Performance

TSX/HBP stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns TSX/HBP?

Insider, institutional, and short-interest positioning.

Institutional ownership

n/a

Share of float held by funds and institutions

Insider ownership

+1.4%

Stake held by company insiders. Higher generally signals alignment.

Short interest

n/a

Float sold short by bearish positioning

Y/Y dilution

+42.4%

Negative means the company is buying back shares.

Technical

TSX/HBP momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

38.3

Neutral momentum band

Price vs 200-day MA

-12.2%

50/200-day relationship not available

Beta (5Y)

-0.31

Less volatile than the market

Sharpe ratio

1.00

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About TSX/HBP

Hub-level FAQ points readers to the deeper analysis pages.

What is the current tsx/HBP stock rating?

tsx/HBP is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full tsx/HBP analysis?

The full report lives at /stocks/tsx/HBP/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for tsx/HBP?

The latest report frames tsx/HBP around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the tsx/HBP page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.